• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SNT 0.00% 1.9¢

SYNTARA LIMITED

Syntara Limited, formerly Pharmaxis Ltd, is an Australia-based clinical-stage drug... Syntara Limited, formerly Pharmaxis Ltd, is an Australia-based clinical-stage drug development company with a focus on blood-related cancers. The Company’s highly productive drug discovery engine is driven by its expertise in amine oxidase inhibitors. Its lead candidate, PXS-5505, is used for the bone marrow cancer myelofibrosis, which causes a build-up of scar tissue that leads to loss of red and white blood cells and platelets. The Company is also advancing both oral and topical pan-LOX inhibitors in scar prevention and scar modification programs. Its PXS-4728 is a SSAO/MAOB inhibitor to treat sleep disorders and slow progression of neurodegenerative diseases like Parkinson’s by reducing neuroinflammation. The Company’s other drug candidates target fibrotic and inflammatory diseases such as kidney fibrosis, NASH, pulmonary fibrosis, and cardiac fibrosis. It has developed two respiratory products: Bronchitol, for cystic fibrosis, and Aridol, a lung function test.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
SNT
Syntara the science explained
10:27 8 1.1K
10:27 Last post  kpax Comments Created with Sketch.  8  Views Created with Sketch.  1.1K 
SNT 09:41 0 116
09:41 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  116 
SNT
SNT JustStocks Video on YouTube
23/05/24 34 6.1K
TRENDING NEWS

Australian-listed companies chase the rainbow of the renewable energy market

NEWS
24 May 2024
23/05/24 Last post  kpax Comments Created with Sketch.  34  Views Created with Sketch.  6.1K 
SNT 17/05/24 0 261
17/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  261 
SNT 10/05/24 13 3.7K
10/05/24 Last post  ContangoPhil Comments Created with Sketch.  13  Views Created with Sketch.  3.7K 
SNT 30/04/24 0 152
30/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  152 
SNT 30/04/24 0 231
30/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  231 
SNT 30/04/24 0 137
30/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  137 

See All Discussions arrow Created with Sketch.

Timeline

Change of registry address notification
24 May 09:21
 
Investor Webinar Presentation
17 May 08:57
 
Application for quotation of securities - SNT
30 Apr 14:54
 
Updated company investor presentation
30 Apr 11:36
 
Presentation for quarterly shareholder briefing
30 Apr 10:38
 
Quarterly Activities Report
30 Apr 08:45
 
View More arrow Created with Sketch.
(20min delay)
Last
1.9¢
Change
0.000(0.00%)
Mkt cap ! $23.88M
Open High Low Value Volume
2.0¢ 2.0¢ 1.9¢ $30.01K 1.574M

Buyers (Bids)

No. Vol. Price($)
2 32222 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 1040275 4
View Market Depth
Last trade - 12.35pm 24/05/2024 (20 minute delay) ?
Last
1.9¢
  Change
0.000 ( 5.00 %)
Open High Low Volume
2.0¢ 2.0¢ 1.9¢ 35000
Last updated 12.34pm 24/05/2024 ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.